Kymera Therapeutics Inc. (KYMR)
NASDAQ · Healthcare
Kymera Therapeutics Inc. Cash on Hand 2019–2025
Kymera Therapeutics Inc. annual cash on hand history from 2019 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Kymera Therapeutics Inc. cash on hand as of December 31, 2025: 357.0M, a 196.88% increase year-over-year.
- Kymera Therapeutics Inc. cash on hand for 2025 were 357.0M, a 196.88% increase from 2024.
- Kymera Therapeutics Inc. cash on hand for 2024 were 120.3M, a 9.36% increase from 2023.
- Kymera Therapeutics Inc. cash on hand for 2023 were 110.0M, a 60.78% increase from 2022.
- Kymera Therapeutics Inc. cash on hand for 2022 were 68.4M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Kymera Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $357 |
| 2024 | $120 |
| 2023 | $110 |
| 2022 | $68 |
| 2021 | $48 |
| 2020 | $31 |
| 2019 | $76 |
Kymera Therapeutics Inc. Cash on Hand — FAQ
Kymera Therapeutics Inc. (KYMR) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KYMR's cash on hand history?
The chart and table above show Kymera Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.